Your browser doesn't support javascript.
loading
Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats.
Levijoki, Jouko; Kivikko, Matti; Pollesello, Piero; Sallinen, Jukka; Hyttilä-Hopponen, Minja; Kuoppamäki, Mikko; Haasio, Kristiina; Gröhn, Olli; Miettinen, Riitta; Puoliväli, Jukka; Tähtivaara, Leena; Yrjänheikki, Juha; Haapalinna, Antti.
Afiliación
  • Levijoki J; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Kivikko M; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Pollesello P; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland. Electronic address: piero.pollesello@orionpharma.com.
  • Sallinen J; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Hyttilä-Hopponen M; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Kuoppamäki M; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Haasio K; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
  • Gröhn O; A.I.Virtanen Institute for Molecular Sciences, Neulaniementie 2, P.O. Box 1627, FIN-70211 Kuopio, Finland.
  • Miettinen R; Tampere University of Technology, Korkeakoulunkatu 10, FI-33720 Tampere, Finland.
  • Puoliväli J; Cerebricon Ltd., c/o Charles River Laboratories, Microkatu 1, FI-70210 Kuopio, Finland.
  • Tähtivaara L; Cerebricon Ltd., c/o Charles River Laboratories, Microkatu 1, FI-70210 Kuopio, Finland.
  • Yrjänheikki J; Cerebricon Ltd., c/o Charles River Laboratories, Microkatu 1, FI-70210 Kuopio, Finland.
  • Haapalinna A; Critical Care Proprietary Products, Orion Pharma, Orionintie 1, P.O. Box 65, FI-02101 Espoo, Finland.
Eur J Pharmacol ; 750: 132-40, 2015 Mar 05.
Article en En | MEDLINE | ID: mdl-25641751

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Vasodilatadores / Accidente Cerebrovascular / Valsartán / Hidrazonas Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: Eur J Pharmacol Año: 2015 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Vasodilatadores / Accidente Cerebrovascular / Valsartán / Hidrazonas Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: Eur J Pharmacol Año: 2015 Tipo del documento: Article País de afiliación: Finlandia